Indian Journal of Pharmaceutical Education and Research logo
Article

Antibiotic De-escalation Therapy in Neurosurgical Patients with Ventilator-Associated Pneumonia in Intensive Care Unit: A Retrospective Observational Study

1, 1

  1. 1Department of Pharmacy, Faculty of Medicine, University of Malaya- Kuala Lumpur, MALAYSIA.

CORRESPONDENCE

Zoriah Aziz

Department of Pharmacy, Faculty of Medicine, University of Malaya- Kuala Lumpur, MALAYSIA.

zoriah@um.edu.my

Received: 13-07-2016; Accepted: 22-11-2016.

Volume 51, Issue 1 · pp. 144-149 · 2017 · DOI: 10.5530/ijper.51.1.19

ABSTRACT

Context: Antibiotic de-escalation practice is gaining interest in the intensive care units (ICU). However, there is limited evidence to support this approach in neurosurgical patients with Ventilator-Associated Pneumonia (VAP) in ICU.Aims: This study examined the practice of antibiotic de-escalation in neurosurgical patients with VAP in ICU and its impact on mortality. Settings and Design: Retrospective cross-sectional study conducted in an ICU of a public hospital in Malaysia.Methods and Material: The electronic medical records of the patients diagnosed with VAP in the ICU were retrieved and relevant data was collected for analysis. Statistical analysis used: Mann-Whitney U-test and Chi- Square Test were used to compare the differences of continuous and categorical data while Logistic Regression and Cox Regression were used to estimate the influence of de-escalation on mortality.Results: Of the 125 VAP patients identified, only 53 (42.4%) were neurosurgical patients. The mean age of these patients was 40.5±15.3 years old. The patients mainly had late-onset VAP. The most common organisms identified included Pseudomonas aeruginosa (19.6%) and Acinetobacter Multidrug-Resistant Organisms (17.9%) while the most commonly used empirical antibiotic was Cefepime (32%). The proportion of patients with antibiotic de-escalation (10 out of 53) was statistically lower than patients without antibiotic de-escalation (43 out of 53). There was no statistically significant difference in ICU-mortality between the de-escalation (2 out of 10) and non-deescalation groups (6 out of 43). Similarly, for the 28-day mortality and survival analysis, no significant difference was found between the two groups.Conclusions: Antibiotic de-escalation practice in neurosurgical patients with VAP in ICU was not associated with a deleterious effect on survival.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Khan, R. A., & Aziz, Z. (2017). Antibiotic De-escalation Therapy in Neurosurgical Patients with Ventilator-Associated Pneumonia in Intensive Care Unit: A Retrospective Observational Study. Indian Journal of Pharmaceutical Education and Research, 51(1), 144-149. https://doi.org/10.5530/ijper.51.1.19

    Copyright and licence

    © 2017 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0